Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454)

Antimicrob Agents Chemother. 2005 Sep;49(9):3948-51. doi: 10.1128/AAC.49.9.3948-3951.2005.

Abstract

A novel gene, dfrG, encoding a trimethoprim (TMP)-resistant dihydrofolate reductase (DHFR, designated S3DHFR) was cloned from a clinical isolate of methicillin-resistant Staphylococcus aureus. Escherichia coli expressing dfrG was highly resistant to TMP. Recombinant S3DHFR exhibited DHFR activity that was not inhibited by TMP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Anti-Infective Agents / pharmacology*
  • Blotting, Southern
  • Cloning, Molecular
  • Cross Infection / microbiology*
  • Culture Media
  • Drug Resistance, Bacterial
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Folic Acid Antagonists / pharmacology*
  • Humans
  • Methicillin Resistance
  • Molecular Sequence Data
  • Reverse Transcriptase Polymerase Chain Reaction
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / genetics
  • Tetrahydrofolate Dehydrogenase / genetics*
  • Tetrahydrofolate Dehydrogenase / metabolism*
  • Trimethoprim / pharmacology*

Substances

  • Anti-Infective Agents
  • Culture Media
  • Folic Acid Antagonists
  • Trimethoprim
  • Tetrahydrofolate Dehydrogenase